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Abstract
A model has been presented for retrograde transport of certain toxins and viruses from the cell
surface to the ER that suggests an obligatory interaction with a glycolipid receptor at the cell
surface. Here we review studies on the ER trafficking cholera toxin, Shiga and Shiga-like toxins,
Pseudomonas exotoxin A and ricin, and compare the retrograde routes followed by these protein
toxins to those of the ER trafficking SV40 and polyoma viruses. We conclude that there is in fact
no obligatory requirement for a glycolipid receptor, nor even with a protein receptor in a lipid-rich
environment. Emerging data suggests instead that there is no common pathway utilised for
retrograde transport by all of these pathogens, the choice of route being determined by the
particular receptor utilised.
Introduction
A model for retrograde transport of ER-trafficking toxins
and viruses from the cell surface to the ER suggests an
obligatory interaction with a glycolipid receptor at the cell
surface (1).
The bacterial and plant protein toxins that disrupt mam-
malian cell signalling, cytoskeletal assembly, vesicular
trafficking or protein synthesis have cytosolic molecular
targets, so at least a portion of the toxin must cross a cel-
lular membrane.
In some cases this is achieved by piercing a biological
membrane. This can be the plasma membrane (pertussis
adenylate cyclase toxin from Bordetella pertussis [2],  α
enterotoxin from Staphylococcus aureus [3], and aerolysin
from Aeromonas hydrophila [4,5]) or, after endocytosis, the
endosomal membrane (diphtheria, anthrax, and botuli-
num toxins. [6-8]).
Cholera toxin [9,10], Shiga and the very closely related
Shiga-like toxins (STx family) [11], Pseudomonas exotoxin
A (PEx) [12] and the plant toxin ricin [13] seem unable to
disrupt cellular membranes directly. After binding their
respective receptors at the cell surface, all travel from the
cell surface to the endoplasmic reticulum (ER) [14-17],
presumably to take advantage of a pre-existing cytosolic
entry mechanism. The toxic portions of all these ER-traf-
ficking toxins have unusually low lysine contents so they
should be poor substrates for ubiquitination and subse-
quent proteasomal degradation in the cytosol. Recogni-
tion of this led to the proposal that these toxic subunits
somehow subvert the ERAD (ER-associated protein degra-
dation) pathway [18], which is the process by which ter-
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minally misfolded proteins in the ER lumen are sorted
and exported to the cytosol for destruction. Seen in his
light, the low lysine complement of these toxins would
permit avoidance of degradation, the ultimate fate of nor-
mal ERAD substrates. These ER trafficking proteins have
thus become tools for probing ERAD and retrograde traf-
ficking pathways.
A number of enveloped viruses such as HIV are able to
fuse directly with the host cell plasma membrane to facil-
itate entry of viral components into the cytosol. Other
enveloped viruses such as influenza and non-enveloped
viruses such as adenovirus enter the target cell by receptor-
mediated endocytosis through clathrin-coated pits. Subse-
quently, these traffic via the late endosome/lysosome
pathway, where they are dismantled prior to endosomal
escape. For influenza virus and other enveloped viruses,
nucleocapsid delivery to the cytosol requires the low pH
environment of the endosome to trigger exposure of a
hydrophobic peptide buried within the virus fusion pro-
tein, which then stimulates fusion of the viral and endo-
somal membranes [19]. There is a clear parallel here with
diphtheria toxin, where the low pH of the endosome trig-
gers a conformational change in the toxin, permitting
engagement of previously occluded tryptophan residues
with the endosomal membrane [20]. Exposure of cells to
bafilomycin A, an inhibitor of the vacuolar-type H(+)-
ATPase responsible for acidifying endosomes, protects
them from infection with influenza [21] and from the
toxic effects of diphtheria toxin [22].
Strikingly, for productive infection of the non-enveloped
viruses simian virus 40 (SV40) and Polyomavirus (Py),
there is demonstrable receptor-mediated but clathrin-
independent, caveolae-dependent endocytosis followed
by obligatory trafficking to the ER. The details of the proc-
ess(es) by which non-enveloped viruses enter the cyto-
plasm are currently not well clarified.
Overall, the sites of cytosolic entry of viruses mirror those
of protein toxins. This raises the following questions – do
toxins and viruses that depend upon retrograde trafficking
follow common routes? Are the membrane-breaching
mechanisms similar, because they are defined by the
nature of the membrane to be traversed, rather than the
nature of the virus or toxin? If so, can retrograde-traffick-
ing toxins be used as probes of pathways utilised by some
viruses?
Here we review studies that define the molecular mecha-
nisms for retrograde transport of protein toxins to the
cytosol, and compare these to known requirements for
SV40 and Py viral trafficking and cytosolic entry. Where
possible, we base our conclusions on routes that are
shown to be productive (for cytotoxicity or infection),
since indirect fluorescence localisation may also identify
trafficking routes that are non-productive: for example,
only a small proportion (~5%) of the ricin that binds a
cell traffics (productively) via the trans-Golgi network
(TGN), with the remainder directed towards (non-pro-
ductive) recycling or degradative routes [23].
ER-trafficking toxin structure and function
Each of the ER-trafficking toxins CTx, STx, PEx and ricin
has a catalytic (toxic) A chain associated with either one
(PEx and ricin) or five (CTx and STx) cell binding B
chains. All are synthesised in non-toxic pro-form, and are
subsequently activated by proteolytic cleavage. This
releases the A subunit from its A-B precursor (PEx and
ricin) or separates a precursor A polypeptide into A1- and
A2-chains (CTx and STx). The cleaved products remain
disulphide bonded in the mature toxin.
CTx A chain is an ADP-ribosyltransferase that modifies the
heterotrimeric G protein Gs-α to activate adenylyl cyclase
[24] inducing intestinal chloride secretion, which leads to
the massive secretory diarrhoea associated with cholera
[25]. At the C-terminus of the CTx A chain is a KDEL ER
retention motif, suggesting that the toxin can interact with
the KDEL receptor. This receptor recycles between the
TGN, Golgi cisternae and the ER, scavenging itinerant sol-
uble ER components and returning them to the ER.
The STx A-subunit and ricin A chain (RTA) are RNA N-gly-
cosidases that remove a conserved adenine residue from
28S rRNA [26,27]. This adenine forms part of a motif that
is the site of interaction with the EF-2 ternary complex, so
intoxication results in cessation of protein synthesis, and,
ultimately, cell death [28].
The A chain of PEx ADP-ribosylates elongation factor 2
[12], preventing protein synthesis and leading to cell
death. The C-terminus of its A chain contains a KDEL-like
sequence.
From the cell surface to the ER
Surface binding and cell entry
ER-trafficking toxins bind membrane receptors via their B
chain(s) and then enter the cell by endocytosis (Figure 1)
[15,16].
CTx B chain binds a membrane glycolipid, the ganglioside
GM1 [29,30] with up to 5 gangliosides being bound per
holotoxin molecule, contributing to a theoretically high
avidity of binding. The STx family members are also gly-
colipid-specific, interacting with the trisaccharide domain
of globotriaosylceramide (Gb3/CD77) [31-33]. Each STx
B subunit has 3 receptor binding sites, so the potential
avidity of binding is very high [34]. Cross-linking of Gb3
promotes toxin recruitment into cell surface lipid raftsVirology Journal 2006, 3:26 http://www.virologyj.com/content/3/1/26
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prior to cell entry [35-37], and also stimulates intracellu-
lar signalling cascades that result in cytoskeletal remodel-
ling [38-41]. Thus, binding of STx may stimulate and
control its own endocytosis.
Ricin B chain (RTB) is a lectin that binds exposed β1-4
linked galactosides [42]. Cell binding is highly promiscu-
ous because a wide range of cell-surface glycoproteins and
glycolipids display these galactosides. Ricin receptors
appear to be largely proteinaceous in nature [43]. How-
ever, the combination of high number of binding sites per
cell and the low affinity of binding [44,45] means that, to
date, no specific ricin receptors have been defined. Since
RTB has two galactose-binding sites, there is potential for
cross-linking of receptors by toxin challenge, with subse-
quent establishment of signalling cascades.
PEx binds a membrane protein, the α2-macroglobulin
receptor/low-density lipoprotein receptor-related protein
[46]. In contrast to all the other ER-trafficking toxins
known, its crystal structure gives no suggestion of high
valency binding to its receptor [47].
Binding of these ER-trafficking toxins to their respective
receptors is required for endocytosis, which occurs by
multiple mechanisms, delivering the toxins to the early
and recycling endosomal (EE/RE) compartment [48].
During this early entry process, if required, activation of
the toxin by furin cleavage will occur. CTx and ricin are
pre-activated. CTx is activated by mammalian intestinal
enzymes prior to target cell binding, and ricin activation
occurs in the seeds of the producing plant, Ricinus commu-
nis. In the EE/RE environment the A subunit of STx is
cleaved into disulphide-linked 29 kDa A1 and 3 kDa A2
chains and the PEx proenzyme is cleaved to produce an N-
terminal B chain of 28 kDa disulphide-linked to a C-ter-
minal A chain of 37 kDa.
Like CTx and STx, SV40 and Py bind glycolipid receptors
in the plasma membrane of host cell [49]. SV40 binds the
ganglioside GM1 and Py binds the gangliosides and GD1a
and GT1b.
In some cells, SV40 enters via caveolae and infection is
inhibited by caveolar disrupting agents such as the choles-
terol-binding methyl-ß-cyclodextrin (MßCD) and the
cholesterol depleting nystatin [50-53]. Py enters at least
some mouse cells by a pathway that depends neither on
caveolae nor on clathrin [54] and infection of primary
baby mouse kidney epithelial cells and established
murine fibroblasts by Py is insensitive to disruption of
caveolar function by treatment with either MßCD or nys-
tatin. These findings strongly suggest that uptake of these
two related viruses in the same cells follows different
pathways. These results stand in contrast to those with
other mouse cell lines in which Py infectivity was found to
be significantly inhibited by treatment with MßCD [55].
Different host cells may therefore differ in their suscepti-
bilities to different cholesterol-binding drugs used to
assess caveolar function and virus uptake. It is also possi-
ble that the same virus may utilize different cellular path-
ways for uptake indifferent cells. Indeed, in a caveolin-1
Generalised simplified retrograde routes available to ER traf- ficking toxins and viruses Figure 1
Generalised simplified retrograde routes available to ER trafficking 
toxins and viruses. Association of the toxin/receptor complex 
or virus/receptor complex with a receptor in detergent 
resistant membrane microdomains (DRM) facilitates uptake 
in caveosomes (C) or transport from early/sorting endo-
somes (EE/SE) to the TGN, directing a proportion of the 
toxin or virus away from the late endosome (LE)/lysosome 
(L) pathway and subsequent destruction. A clear exception is 
Pseudomonas exotoxin A, which can also utilise a LE to TGN 
pathway to avoid lysosomal destruction. For toxins, trans-
port from the TGN to the ER may proceed via the Golgi 
stack or may be direct: for SV40 and Py, ER transport 
appears to proceed directly from caveosomes.Virology Journal 2006, 3:26 http://www.virologyj.com/content/3/1/26
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(cav-1)-deficient cell line (human hepatoma 7) and
embryonic fibroblasts from a cav-1 knockout mouse,
SV40 exploits an alternative, cav-1-independent pathway
and this alternative pathway is also available in wild-type
embryonic fibroblasts [56]. Internalization here is choles-
terol and tyrosine kinase dependent but independent of
clathrin, dynamin II, and ARF6. The viruses were internal-
ized in small vesicles and transported to membrane-
bound, neutral pH organelles similar to caveosomes but
lacking the caveolar markers cav-1 and -2. They were next
transferred by microtubule-dependent vesicular transport
to the ER, a step required for infectivity.
From the endosomes to the TGN
At least two retrograde pathways proceed from endo-
somes to the TGN (Figure 1); [57-60]. One is dependent
on the small GTPase Rab9 and operates from late endo-
somes (LE) [61]. The other is Rab9-independent and leads
from an early endosomal (EE) compartment [17] These
pathways also depend on separate vesicle- and target-
organelle-soluble  N-ethylmaleimide-sensitive fusion
attachment protein receptor complexes (v-SNAREs and t-
SNAREs, respectively) to achieve fusion of intracellular
vesicles.
For the glycolipid-specific CTx and STx family, transport
from early endosomes to the TGN depends on lipid trans-
port and requires a critical association with detergent
resistant membrane microdomains (DRM). STx retro-
grade transport depends on the TGN t-SNARES syntaxins
5 and 16 [62], and on the Arl1 GTPase effector Golgin-97
[63]. CTx enters cells in vesicles containing the early endo-
some marker Rab5 but lacking lysosomal markers [64].
Subsequently, it accumulates in a discrete population of
endosomes lacking classical EE markers en route to the
TGN [65]. From the early endosome to the TGN, CTx traf-
fics in Arl1 dependent vesicles [63] indistinguishable
from those that carry STx [66]. Thus, like STx, productive
routing of CTx is thought to avoid the late endosomes and
lysosomes in a Rab9-independent manner.
Association with lipid-rich plasma membrane domains
and subsequent Rab5 dependent trafficking into a cell
seem to be common entry strategies, even appearing to be
mandatory for productive HIV-1 infections in non-CD4+
cells [67]. A clear exception is PEx. Whilst a proportion of
cell bound PEx can traffic in this manner in HeLa cells, the
majority enters cells independently of DRM association
and is sorted at the early/recycling endosome compart-
ments in a non-lipid dependent manner [68], subse-
quently trafficking to the TGN in a Rab9-dependent
manner from late endosomes. In murine Swiss 3T3 cells,
PEx appears to be constrained to this Rab9-dependent
route. Ricin receptors are predominantly proteinaceous
[43], so ricin might be expected to follow a similar route,
but in fact its transport is Rab9-independent [69] and sen-
sitive to MβCD [70], and some enters cells in Rab5-posi-
tive vesicles [71], so at least a proportion of ricin
trafficking appears to be CTx-like and STx-like from the
cell surface to the TGN.
From the TGN to the ER
At least two routes have been described for protein toxin
travel from the TGN to ER, but recent work with toxins
suggests a third very poorly characterised route exists (Fig-
ure 1).
In the first, there is a critical dependence on binding KDEL
receptors which cycle between the TGN and the ER via the
Golgi cisternae [72] in a COP1-dependent manner and
which typify retrograde transport in the classic secretory
pathway [73,74]. PEx trafficking down the Rab9-depend-
ent route needs to disengage from its primary receptor and
then associate with KDEL receptors. Since the A chain of
PEx terminates in a KDEL-like sequence, it is thought that
the KDEL-receptor then delivers PEx from the TGN into
the lumen of the ER [68,75-78]. This pathway appears to
be very important for PEx as PEx transport is accelerated
after inhibition or genetic ablation of the tyrosine kinase
Src [79], which regulates KDEL-receptor distribution.
In a second TGN to ER pathway, the lipid-sorted pathway
utilised by STx traffics from the TGN to the ER in a COP-I
independent manner, in a manner controlled by Rab6
[59,80-82]. PEx bound to DRM at the cell surface, which
enters the cells in a Rab9-independent manner, can also
traffic via this route [68].
In the third pathway, CTx moves directly from the TGN to
the ER without passing through the Golgi cisternae [83]
and therefore independently of COP-I vesicles and the
KDEL receptor. What, then, is the function of the KDEL
sequence at the C-terminus of the A2 chain of CTx? It is
proposed that this prevents CTx delivered by lipid recep-
tors moving anterograde from the ER to the cis Golgi: thus
the KDEL sequence acts as a recycling accumulator, pro-
moting high concentrations of CTx in the ER for subse-
quent dislocation of the A1-chain to the cytosol.
Ricin's promiscuous binding and the lack of defined
receptors lead to poor knowledge of events between the
TGN and the ER. Ricin lacks a KDEL retention sequence,
but can interact with the chaperone calreticulin in the
Golgi complex. Calreticulin has a KDEL-motif, and may
traffic to the ER in the COP-I dependent pathway by bind-
ing the KDEL-receptor when bound to ricin [84], although
this is unlikely to be a major route, since calreticulin-defi-
cient cells remain equally sensitive to ricin. Ricin can also
bind glycolipids that contain terminal galactose, and so a
proportion may follow lipid sorting signals. The TGN-to-Virology Journal 2006, 3:26 http://www.virologyj.com/content/3/1/26
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ER pathways exploited by ricin remain unclear however,
since RTA can kill cells inhibited simultaneously in both
the classical COP1-dependent and Rab6-dependent path-
ways [85], suggesting that ricin can also bypass the Golgi
stack in a CTx-like manner.
Bypassing the TGN and Golgi stack
Details of the pathways taken by SV40 and Py to reach the
ER are still under investigation. After infection Py can be
co-localized with the ER luminal protein BiP [86]. SV40
infection is strongly inhibited by expression of GTP-
restricted Arf1 and Sar1 mutants and by microinjection of
antibodies to β-COP, suggesting that infection requires
COP-I-dependent transport steps for successful infection
[87]. Subsequent transport to the ER is sensitive to the
fungal metabolite brefeldin A (BFA) [88] which, in cells
with a BFA-sensitive Golgi apparatus, causes fusion of
Golgi and ER membranes, and thus disrupts both antero-
grade and retrograde trafficking between these organelles.
These results appear to implicate the Golgi apparatus as a
staging post for the viruses en route to the ER. However,
although SV40 co-localizes with β-COP it does not co-
localise with Golgin-97 [89], which at steady state resides
in the TGN [90,91]. β-COP is also a marker of caveosomes
[92] as well as the Golgi [93-96]. The BFA sensitive retro-
grade step is thus likely to reflect blocking of caveosomal/
endosomal escape, rather than a requirement for the
Golgi, since BFA treatment also results in fusion of endo-
somal, lysosomal and TGN membranes [97]. Thus the
caveosome appears to be a BFA-sensitive sorting organelle
from which at least two distinct routes emerge, separating
the retrograde trafficking of CTx and SV40 [98,99] (Figure
1). The former proceeds to the TGN via the EE, whilst the
virus traffics directly from the caveosomal early sorting
vesicle to the ER thereby bypassing the TGN and the Golgi
stack. Curiously, unusual ricin trafficking directly from an
early sorting vehicle to the ER can be induced in CHO cells
carrying a temperature sensitive ε-COP under conditions
where ε-COP is inactivated [100]: the promiscuity of ricin
binding may allow it to access an SV40-like retrograde
route when its normal retrograde routes are unavailable.
The ER provides necessary unfolding activities
The ER is a site from which misfolded proteins can be dis-
located via the Sec61 translocon to the cytosol in the proc-
ess termed ERAD. At least one correctly folded protein,
(calreticulin, normally regarded as an ER resident), can
also be unfolded to enter the cytosol from the ER, via the
translocon, and refolds in the cytosol to avoid degrada-
tion [101]. Since the translocon has a narrow pore
[102,103], there is thought to be a requirement for
unfolding, and this requires protein chaperones, an abun-
dance of which reside in the ER lumen. Presumably toxins
and viruses that traffic to the ER do so to take advantage
of these pre-existing unfolding and cytosolic entry mech-
anisms.
Mature, activated (proteolytically cleaved) toxins arriving
in the ER have their A and B or their A1- and A2-chains
tethered by a disulphide bond. Ricin holotoxin is inactive
against free ribosomes in vitro, because the B chain hinders
A chain catalytic activity [104], so reduction of the subu-
nits is a requisite for cytotoxicity. This is assumed to be the
case for the other ER-trafficking toxins.
ER-delivered CTx is a substrate for the ER chaperone pro-
tein disulphide isomerase (PDI), which dissociates the
A1-chain from the rest of the toxin [105] and then
reduced PDI unfolds the released A1-chain. At the ER
membrane, the ER oxidase ERO1 catalyzes the re-oxida-
tion of PDI, releasing the unfolded A1-chain to the dislo-
cation machinery [106]. The ER chaperone BiP may also
participate in unfolding CTx A1-chain [107]. PDI may
also reduce PEx [108], and it is assumed that PDI, or some
other reducing agent, is also responsible for separating the
A1- and A2-chains of STx.
Reduced PDI also reduces ricin into constituent A and B
subunits [45], with a role for thioredoxin reductase as an
agent for reducing PDI [109]. Liberated RTA interacts with
negatively-charged lipids, undergoing structural changes
and promoting membrane instability [110]. ER chaper-
ones might also recognize newly exposed RTA domains to
catalyze unfolding reactions. It is thought that partially
unfolded RTA now masquerades as an ERAD substrate,
interacting with ER components that direct them from the
ER to the cytosol. Evidence for a functional correlation
between ERAD and sensitivity to ER-directed toxins has
been provided by mutant cell lines that display either
decreased or increased ERAD activities [111,112]. Thus
PDI-catalysed unfolding of CTx and partial unfolding of
RTA at a lipid membrane may allow their recognition as
misfolded substrates for ER components normally associ-
ated with ERAD. Consistent with this notion, STx interacts
with the ER luminal chaperone HEDJ/ERdj3, in a complex
that includes the ER chaperones BiP and GRP94 and also
the Sec61 translocon [113].
The membrane penetration of non-enveloped ER-traffick-
ing viruses is a poorly understood process. Strikingly,
though, a requirement for interaction with an ER oxidore-
ductase related to PDI has recently been described [114],
suggesting that interactions with ER chaperones are as
important for ER-trafficking viruses as they are for ER-traf-
ficking toxins. A PDI-like protein, ERp29, triggers a con-
formational change in the Py protein VPI, partially
unfolding it to expose its C-terminal arm. ERp29-modi-
fied VP1 can interact with liposomes, and by extension,
probably therefore with the ER membrane, in preparationVirology Journal 2006, 3:26 http://www.virologyj.com/content/3/1/26
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for membrane penetration. In support of this, expression
of the dominant-negative N terminal domain of ERp29
decreases Py infection, indicating ERp29 facilitates viral
infection.
Dislocation
After a protein is identified as an ERAD substrate, it is
exported from the ER to the cytosol for destruction. Exper-
iments showing mammalian ER export of dislocated
MHC class I heavy chains mediated by the product of the
cytomegalovirus US2 gene, [115,116] and studies with
specific yeast mutants [117,118], first suggested that
export in both systems involved the Sec61 translocon in a
reversal of the process by which nascent secretory proteins
are delivered into the ER lumen. Both CTx and ricin can
be co-immunoprecipitated with sec61 [119,120]. There is
also evidence that PEx can use the Sec61 complex for dis-
location [121]. For STx, interactions of the toxin with ER
chaperones in a complex that includes the Sec61 translo-
con suggest that this toxin also utilises the translocon for
egress from the ER [113].
The driving force for ER dislocation of any protein toxin
remains unknown, but it is likely that this is supplied by
a cytosolic motor. Almost all terminally misfolded pro-
teins known to be dislocated are poly-ubiquitinated on
lysine residues, but a mutant CTx A1 chain with its N-ter-
minus chemically blocked and all lysines mutated to
arginine [122] and a ricin holotoxin reconstituted from
plant-derived RTB and a recombinant RTA lacking all
lysines [123] remain fully toxic. The AAA-ATPase p97 and
its adaptor molecules Ufd1 and Npl4 are involved in dis-
location of some ERAD substrates and it seems reasonable
to suggest that they may be involved in toxin dislocation,
but to date, the data conflict [124,125].
How the membrane-embedded Py reaches the cytosol is
currently unknown. The low cholesterol concentration of
the ER membrane makes it passively permeable to small
molecules which are unable to cross the plasma mem-
brane or the lysosomal and trans-Golgi membranes [126].
This general property could allow the virus-membrane
interaction to induce holes in the bilayer by disrupting the
phospholipid organization, thereby enabling the virus to
egress the ER. Cytosolic chaperones could bind to the
exposed hydrophobic regions of Py on the cytosolic sur-
face of the ER membrane and extract the virus into the
cytosol, similar to the manner proposed for dislocating
toxins through the ER translocon. Overall it is clear that
the motor(s) required for dislocation of protein toxin sub-
units and viruses remain a mystery.
Conclusion
Figure 1 depicts generalised retrograde transport routes,
but of necessity, shows a degree of over-simplification.
Thus, SV40 transport is shown to proceed from caveo-
somes, although this is not obligatory for infection
[56,99] so there may be further sorting in early endo-
somes; ricin and CTx transport is depicted as STx-like from
early endosomes to the TGN, although there may be mul-
tiple routes; and CTx and ricin are depicted as following a
single route from the TGN to the ER, but this is poorly
characterised, without known markers. Furthermore,
there are cell-type differences in entry of CTx [127], PEx,
[68] and SV40. Also, entry route may alter at different con-
centrations of virus or toxin, and molecular disturbance of
one trafficking pathway may induce others. Finally, we
have tried to limit this compiled figure to routes known to
be productive for viral infection or intoxication. For exam-
ple, treatment of cells with MßCD has very little effect on
total ricin endocytosis [128], but strongly attenuates cyto-
toxicity [70] suggesting that the majority of endocytosed
ricin is recycled or degraded.
Nevertheless, the Figure points out that ligands with a
common receptor (eg. SV40 and CTx) can reach the ER by
different routes, and that a toxin with a single known pro-
tein receptor (PEx) can access different routes dictated by
cell-surface binding events [68]. Despite observations of
co-localisation of CTx and SV40 in caveolae [89,129,130],
a common Rab5-dependent trafficking of CTx, Stx, Py and
SV40 from such structures to early endosomes [66,99] and
a proposal that interaction with detergent resistant mem-
branes is required for ER transport [1], we suggest that
there are very few aspects in common between the retro-
grade routes available to the viruses Py and Sv40 and ER-
trafficking toxins. It is more likely that rather than all
being constrained to one retrograde route, each virus or
toxin traffics in a manner determined by its own peculiar
interaction with receptor. However, the site of cytosolic
entry provides insights into common mechanisms. Low
pH-stimulated conformational changes in influenza pro-
teins and diphtheria toxin are appropriate for endosomal
escape. For the ER trafficking viruses and toxins, then, pre-
sumably common interactions are made, defined not by
the nature of the ER trafficking entity, but the nature of the
ER lumen. Strikingly, members of the ER oxidoreductase
family are seen to be important. These promote reduction
of toxin subunits, but may also reductively activate Py VP1
since the effects of ERp29 are amplified in reducing con-
ditions that could mimic PDI action [114]. Furthermore
members of this family are also implicated in stimulating
conformational changes in both toxins and viral proteins.
To date, details of ER escape mechanisms are poorly
understood, beyond a likely requirement for the Sec61
translocon for toxins, but we fully expect dislocation
motors for both toxins and viruses to show strong similar-
ities.
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